China Bio Energy Reports Fourth Quarter and Record 2008 Financi... (of $0.13 per diluted share compared tone...)

China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results

Date:3/23/2009

of $0.13 per diluted share compared to net income of $2.1 million, and a loss of $.05 per diluted share, in the fourth quarter of 2007. Diluted weighted average shares outstanding were 32.9 million and 25.1 million for the fourth quarter of 2008 and 2007, respectively. Adjusted net income for the fourth quarter of 2008, excluding the $9.8 million charge in stock-based compensation expenses related to the ''Make Good'' provision of an October 2008 financing agreement, was $6.5 million or $0.17 per diluted share, which represented a 209.5% increase, compared to the same period in 2007.

Fiscal Year 2008 Financial Results

Sales - Sales for 2008 were $216.5 million, an increase of 149% compared to $87.1 million in 2007. The increase was mainly due to strong growth in bio-diesel sales with production increasing to 58,701 tons in 2008 from 5,836 tons in 2007, solid increases in the Company's distribution segment to existing and new customers, in addition to sales generated by the four newly leased gas stations, which were not managed during 2007.



    Fiscal Year 2008 Revenue Breakdown
                                       FY 2008         FY 2007        CHANGE
    Distribution of Finished Oil   $143.4 million   $82.9 million     +73.0 %
    % of Sales                           66.3%          95.2%
    Bio-Diesel Production           $50.1 million    $4.2 million   +1092.8 %
    % of Sales                           23.1%           4.8%
    Retail Gas Stations             $23.0 million        N/A            N/A
    % of Sales                           10.6%           N/A
    Total Sales                    $216.5 million   $87.1 million      +149 %

Cost of Sales - Cost of sales for 2008 was $185.9 million compared to $77.0 million in 2007, an increase of $108.9 million, or 141%. The increase was due to the sharp rise in production and sales activities during 2008. Cost of sales as a pe
'/>"/>

SOURCE China Bio Energy Holdings Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related biology technology :

1. aTyr Pharma to Present at ChinaBio(R) Investor Forum in Hong Kong
2. Niusule Biotech Corp. Formally Establishes a New Venture to Import and Sell Health Foods in the Peoples Republic of China
3. China-Biotics, Inc. Appoints New Chief Financial Officer
4. China Medical Technologies Senior Management Purchased Company Shares
5. China Bio-Immunity Corporation - Rabies Vaccine Recall
6. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
7. China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets
8. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
9. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
10. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
11. OriGene Technologies, Inc. Establishes High Throughput Monoclonal Antibody Production Outsourcing Center in China

Post Your Comments:

(Date:12/16/2009)... Mass., Dec. 16 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, according ... Stelara and Abbott,s briakinumab (both interleukin inhibitors) will ... 2012 in the drug market for moderate to ... experience greater uptake, capturing nearly three times as ...

(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...

(Date:12/15/2009)... Dec. 15 Epeius Biotechnologies Corporation, an ... medicine, gained international validation of the cutting-edge science ... when scientists around the world rediscovered the ... locus of cancer pathogenesis and disease progression, and ... scientists at the NIH National Cancer Institute investigating ...

(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...

[0] In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market [0] Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance [0] Scientists Rediscover Gene Target for Cancer Therapy [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement

... ROCKVILLE, Md., Feb. 19 Human Genome,Sciences, Inc. (Nasdaq: ... a,conference call to discuss its financial results for the ... be disclosed on Monday,February 25, 2008, after the capital ... The conference call will be hosted by senior management ...

... Campbell Alliance, the leading,management consulting firm ... announced that executives from its Brand Management ... 4th Annual Forum on Early,Stage Product Development ... by the Center for Business Intelligence,(CBI). The ...

... BRISTOL, Tenn., Feb. 19 Graceway Pharmaceuticals, LLC,("Graceway"), ... announced,today that it has acquired all of the ... America from Novavax, Inc.,("Novavax") (Nasdaq: NVAX ) ... is indicated for the treatment of moderate to ...

Other Biology Technology:Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2007 Financial Results 2 Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 2 Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 3 Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference 4 Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX) 2

Human Genome Sciences to Sponsor Conference Call to Discuss Full Year 2007 Financial Results Campbell Alliance Brand Management and Managed Markets Practices to Speak at CBI's Early Commercialization Conference Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)

(Date:12/16/2009)... in Scotland, Canada and the US have proposed ... whale conservation. The team,s findings, published in ... areas, identified through feeding behaviour, can benefit highly ... "There are enormous challenges associated with setting conservation ... whales," said lead author Erin Ashe, a PhD ...

(Date:12/16/2009)... Energy Steven Chu announced today the winners of the ... research and development supporting the Department of Energy and ... receive a gold medal, a citation and $50,000. ... Washington, DC early next year., "The contributions made by ... security of the United States are wide-ranging and meaningful," ...

(Date:12/16/2009)... of interactions. Today,s techniques, however, can only be ... cells. Since molecular concentrations are much higher in ... the kinetics of molecular reactions in living cells ... cellular reaction speed to be higher," confirms LMU ... approach showed that depending on the length ...

Breaking Biology News(10 mins):Zoning the ocean may help endangered whales to recover 2 Zoning the ocean may help endangered whales to recover 3 Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners 2 Looking for the heartbeat of cellular networks 2 A Sacred Celebration 3A Georgetown School of Medicine Honors Donors 48227 1 A Sacred Celebration 3A Georgetown School of Medicine Honors Donors 48227 2 BIOCOMs Inaugural CALAsia Forum Bridging the Pacific 12530 1 BIOCOMs Inaugural CALAsia Forum Bridging the Pacific 12530 2 The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 1 The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 2 The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide 4568 3

[0] Zoning the ocean may help endangered whales to recover [0] Secretary Chu announces 2009 Ernest Orlando Lawrence Award winners [0] Looking for the heartbeat of cellular networks

... physics curricula in US universities are sorely in need of ... Way Forward, to be held January 31 - February 2, ... a candid look at graduate physics programs and consider ways ... physicists for future challenges. , The conference, to ...

... The Stowers Institutes Proteomics Center has published a novel ... series of affinity purifications analyzed by mass spectrometry (APMS) ... proteins to associate with one another. , ... probabilities not only to the interactions within well-defined protein ...

... DURHAM, N.C. -- A new resource that identifies regions of ... learn about and develop treatments for a number of human ... & Policy (IGSP). , The majority of DNA in our ... a researcher in the IGSP and one of the senior ...

Other Biology News:Stowers Proteomics Center devises method for assigning probabilities to human protein interactions 2 Search for the 'on' switches may reveal genetic role in development and disease 2

Graduate Education in Physics: Which Way Forward?Stowers Proteomics Center devises method for assigning probabilities to human protein interactions Search for the 'on' switches may reveal genetic role in development and disease

Request Info...

Loading Buffer...

Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...

Biology Products:

Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.Toxoplasma IgM ELISA Kit, Single from Bio-Quant Inc.2X Agarose Loading Buffer from Applied Biosystems Gel Loading Dye (Bromophenol Blue, Xylene Cyanol/Glycerol) from Mo Bio Laboratories, Inc.

China Bio Energy Reports Fourth Quarter and Record 2008 Financi...(of $0.13 per diluted share compared tone...)